Monitoring Cell Therapy Using Iron Oxide MR Contrast Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|5|6|567-584

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.5, Iss.6, 2004-12, pp. : 567-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Iron Oxide Based MR Contrast Agents: from Chemistry to Cell Labeling

By  

Current Medicinal Chemistry, Vol. 16, Iss. 35, 2009-12 ,pp. : 4712-4727

Bentham Science Publishers

Access to resources Recommend Favorite

Activated MR Contrast Agents

By  

Current Pharmaceutical Biotechnology, Vol. 5, Iss. 6, 2004-12 ,pp. : 519-528

Bentham Science Publishers

Access to resources Recommend Favorite

Magnetic Resonance Imaging of Cell Surface Receptors Using Targeted Contrast Agents

By  

Current Pharmaceutical Biotechnology, Vol. 5, Iss. 6, 2004-12 ,pp. : 485-494

Bentham Science Publishers

Access to resources Recommend Favorite

Dose Radiopharmaceutical Science Makes Sense/Over on MR Contrast Media Agents or Not?

By  

Current Radiopharmaceuticals, Vol. 3, Iss. 4, 2010-10 ,pp. : 284-285

Bentham Science Publishers

Access to resources Recommend Favorite

Phase-Change Contrast Agents for Imaging and Therapy

By  

Current Pharmaceutical Design, Vol. 18, Iss. 15, 2012-05 ,pp. : 2152-2165

Bentham Science Publishers

Access to resources Recommend Favorite